VR Adviser, LLC Q4 2023 Filing
Filed February 14, 2024
Portfolio Value
$1.5B
Holdings
36
Report Date
Q4 2023
Filing Type
13F-HR
All Holdings (36 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —RAYZEBIO INC | 4,030,471 | $250.6T | 17185381.88% | |
| 2 | APGEAPOGEE THERAPEUTICS INC | 8,493,321 | $237.3T | 16275204.71% | |
| 3 | PHVSPHARVARIS N V | 3,395,606 | $95.2T | 6532398.58% | |
| 4 | VRDNVIRIDIAN THERAPEUTICS INC | 3,882,623 | $84.6T | 5799701.18% | |
| 5 | FDMT4D MOLECULAR THERAPEUTICS IN | 3,424,031 | $69.4T | 4757728.42% | |
| 6 | MRUSMERUS N V | 2,148,214 | $59.1T | 4051657.78% | |
| 7 | CABACABALETTA BIO INC | 2,563,952 | $58.2T | 3991703.40% | |
| 8 | SYRESPYRE THERAPEUTICS INC | 2,372,714 | $51.1T | 3501951.90% | |
| 9 | KALVKALVISTA PHARMACEUTICALS INC | 4,092,731 | $50.1T | 3438522.03% | |
| 10 | ELVNENLIVEN THERAPEUTICS INC | 2,954,902 | $40.9T | 2804798.68% | |
| 11 | OCULOCULAR THERAPEUTIX INC | 7,775,760 | $34.7T | 2378483.98% | |
| 12 | HLVXHILLEVAX INC | 2,075,000 | $33.3T | 2284102.86% | |
| 13 | AMAMAMBRX BIOPHARMA INC | 2,070,000 | $29.5T | 2021635.49% | |
| 14 | TERNTERNS PHARMACEUTICALS INC | 4,497,117 | $29.2T | 2001711.10% | |
| 15 | DYNDYNE THERAPEUTICS INC | 2,173,913 | $28.9T | 1982970.81% | |
| 16 | COGTCOGENT BIOSCIENCES INC | 4,684,167 | $27.5T | 1889001.12% | |
| 17 | CELCCELCUITY INC | 1,885,538 | $27.5T | 1884158.20% | |
| 18 | —MERSANA THERAPEUTICS INC | 11,328,000 | $26.3T | 1802452.15% | |
| 19 | ARVNARVINAS INC | 627,788 | $25.8T | 1772192.50% | |
| 20 | CATBUSDASTRIA THERAPEUTICS INC | 3,225,806 | $24.8T | 1699111.91% | |
| 21 | RYTMRHYTHM PHARMACEUTICALS INC | 495,983 | $22.8T | 1563737.40% | |
| 22 | ORICORIC PHARMACEUTICALS INC | 2,428,385 | $22.3T | 1532243.85% | |
| 23 | APLTAPPLIED THERAPEUTICS INC | 6,250,000 | $20.9T | 1435976.54% | |
| 24 | TSHATAYSHA GENE THERAPIES INC | 10,412,872 | $18.4T | 1264055.97% | |
| 25 | YB4PSAVARA INC | 3,500,000 | $16.4T | 1128206.04% | |
| 26 | LYRALYRA THERAPEUTICS INC | 2,575,593 | $13.5T | 925616.38% | |
| 27 | ABVXABIVAX SA | 998,570 | $10.7T | 732798.90% | |
| 28 | DNTHDIANTHUS THERAPEUTICS INC | 927,706 | $9.6T | 661707.73% | |
| 29 | PRAXPRAXIS PRECISION MEDICINES I | 353,626 | $7.9T | 540358.36% | |
| 30 | GHRSGH RESEARCH PLC | 1,318,327 | $7.6T | 524413.28% | |
| 31 | SLRNACELYRIN INC | 937,113 | $7.0T | 479461.03% | |
| 32 | EYPTEYEPOINT PHARMACEUTICALS INC | 250,000 | $5.8T | 396243.79% | |
| 33 | TRVITREVI THERAPEUTICS INC | 3,422,397 | $4.6T | 314526.84% | |
| 34 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 5,147,547 | $3.9T | 265767.83% | |
| 35 | MISTMILESTONE PHARMACEUTICALS IN | 925,048 | $1.5T | 105950.55% | |
| 36 | OLMAOLEMA PHARMACEUTICALS INC | 77,042 | $1.1T | 74132.33% |